Home/Filings/4/0002038768-25-000007
4//SEC Filing

Friberg Gregory R 4

Accession 0002038768-25-000007

CIK 0001048477other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:33 PM ET

Size

4.5 KB

Accession

0002038768-25-000007

Insider Transaction Report

Form 4
Period: 2025-09-30
Friberg Gregory R
EVP, Chief R&D Officer
Transactions
  • Tax Payment

    Common Stock

    2025-09-30$54.16/sh3,304$178,94543,506 total

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0002038768

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:33 PM ET
Size
4.5 KB